Study of SDX in Patients With Idiopathic Hypersomnia (IH)

Clinical trial NCT05668754 · COMPLETED

Trial details

NCT number: NCT05668754
Sponsor: Zevra Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Hypersomnia

Start date: 2022-12-28
Primary completion: 2024-02-28
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.